Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis

被引:0
作者
T Mori
Y Aisa
R Yamazaki
A Mihara
Y Ikeda
S Okamoto
机构
[1] Keio University School of Medicine,Division of Hematology, Department of Medicine
来源
Bone Marrow Transplantation | 2006年 / 38卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:637 / 638
页数:1
相关论文
共 50 条
[1]  
Devine SM(2001)Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant Bone Marrow Transplant 28 557-562
[2]  
Sanborn R(2002)Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma Bone Marrow Transplant 30 367-373
[3]  
Jessop E(2002)Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma Blood 100 755-760
[4]  
Stock W(2006)A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation Bone Marrow Transplant 37 1031-1035
[5]  
Huml M(2005)Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplantation Support Care Cancer 13 266-269
[6]  
Peace D(2006)Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients Support Care Cancer 14 392-395
[7]  
Giralt S(1986)Pharmacokinetics of high-dose melphalan in children and adults Cancer Chemother Pharmacol 16 184-189
[8]  
Aleman A(1996)Ice pops to prevent melphalan-induced stomatitis Lancet 347 1691-1692
[9]  
Anagnostopoulos A(1994)Prevention of high dose L-PAM-induced mucositis by cryotherapy Bone Marrow Transplant 3 492-494
[10]  
Anagnostopoulos A(undefined)undefined undefined undefined undefined-undefined